ERBB2 and metastatic malignant neoplasm in the lymph nodes: In subtype analysis, the expression level of miR-155 was significantly correlated with estrogen receptor alpha (ER), progesterone receptor (PR), Her-2, lymph node metastasis, tumor size, and p53 status.